COVID-19 Vaccine Covaxin, Developed by Bharat Biotech, Cleared For Phase 3 Clinical Trials
New Delhi, October 22: Covaxin, India’s first indigenously-developed vaccine candidate against coronavirus (COVID-19), has been cleared by the Drugs Controller General…








